News Focus
News Focus
icon url

BLUEVOODU

05/03/21 6:04 PM

#1476 RE: PressAnyKey- #1475

Interesting Video for sure. Hearing their process is cool. Thank you for sharing, especially a video that's newer and not months old. Once they have their next results, as long as they're successful, BPSR has a chance to take off.

Until then, we are going to be in somewhat of holding / deflating pattern. I welcome the drops as I like to invest more lower. If we hit teens or lower, game on.
icon url

PressAnyKey-

05/03/21 10:22 PM

#1477 RE: PressAnyKey- #1475

$ BPSR the Prequel to the Podcast. (Google EXOSOME THERAPY)[/img]

The long-term effects of COVID-19 infection can’t be comprehensively predicted. We don’t even understand why symptoms last only hours or days in some infected people, if they appear at all, yet linger for weeks and months for those dubbed “COVID long haulers.” Developing innovative biologics to treat COVID long haulers is the current mission of Miami-based Organicell Regenerative Medicine, though the company’s challenging therapy development journey began long before the idea curried much favor.


https://www.bioprocessonline.com/doc/beating-stem-cell-sourcing-exosome-production-challenges-0001